Meishen Technology

Maison Technology, also known as Meishen Technology, is a leading Chinese biotechnology company specializing in high-resolution single-cell sequencing and spatial transcriptomics. Founded in 2018 and headquartered in Shanghai, the company provides a comprehensive suite of multi-omics services designed to decode complex biological systems. Their platform integrates advanced molecular biology techniques with proprietary bioinformatics algorithms to support applications in oncology, immunology, and developmental biology. Maison Technology serves as a key partner for pharmaceutical companies and academic researchers, facilitating the discovery of novel therapeutic targets and biomarkers. The company is recognized for its ability to deliver high-quality, scalable genomic data that accelerates the development of precision medicines.